<?xml version='1.0' standalone='yes'?>
<rdf:RDF   xml:base="http://purl.obofoundry.org/obo/obi/PlanAndPlannedProcess.owl"
   xmlns="http://purl.obofoundry.org/obo/"
         xmlns:bfo="http://www.ifomis.org/bfo/1.1#"
         xmlns:cell="http://purl.org/obo/owl/CL#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:dcterms="http://purl.org/dc/terms/"
         xmlns:go="http://www.geneontology.org/formats/oboInOwl#"
   xmlns:obi="http://purl.obofoundry.org/obo/"
   xmlns:obi_annot="http://purl.obofoundry.org/obo/obi/AnnotationProperty.owl#"
   xmlns:obi_biomat="http://purl.obofoundry.org/obo/obi/Biomaterial.owl#"
   xmlns:obi_data_trans="http://purl.obofoundry.org/obo/obi/DataTransformation.owl#"
   xmlns:obi_denrie="http://purl.obofoundry.org/obo/obi/DigitalEntityPlus.owl#"
   xmlns:obi_ext="http://purl.obofoundry.org/obo/obi/external.owl#"
   xmlns:obi_extd="http://purl.obofoundry.org/obo/obi/externalDerived.owl#"
   xmlns:obi_func="http://purl.obofoundry.org/obo/obi/OBI-Function.owl#"
   xmlns:obi_instr="http://purl.obofoundry.org/obo/obi/InstrumentAndPart.owl#"
   xmlns:obi_obsolete="http://purl.obofoundry.org/obo/obi/Obsolete.owl#"
   xmlns:obi_owlfull="http://purl.obofoundry.org/obo/obi/obi-owl-full.owl#"
   xmlns:obi_plan="http://purl.obofoundry.org/obo/obi/PlanAndPlannedProcess.owl#"
   xmlns:obi_quality="http://purl.obofoundry.org/obo/obi/Quality.owl#"
   xmlns:obi_rel="http://purl.obofoundry.org/obo/obi/Relations.owl#"
   xmlns:obi_rest="http://purl.obofoundry.org/obo/obi/TheRest.owl#"
   xmlns:obi_role="http://purl.obofoundry.org/obo/obi/Role.owl#"
         xmlns:owl="http://www.w3.org/2002/07/owl#"
         xmlns:pato="http://purl.org/obo/owl/PATO#"
         xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#"
         xmlns:protege-dc="http://protege.stanford.edu/plugins/owl/dc/protege-dc.owl#"
         xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
         xmlns:ro="http://www.obofoundry.org/ro/ro.owl#"
         xmlns:robfo="http://purl.org/obo/owl/ro_bfo1-1_bridge#"
         xmlns:rotoo="http://purl.org/obo/owl/ro#"
         xmlns:snap="http://www.ifomis.org/bfo/1.1/snap#"
         xmlns:span="http://www.ifomis.org/bfo/1.1/span#"
         xmlns:xsd="http://www.w3.org/2001/XMLSchema#">
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600048">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of a clonal cell line to produce a biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">E coli expressing the gene for M avium p35 were cultured in order to produce p35.</OBI_0000287>
    <OBI_0000288 xml:lang="en">amplification of a clone</OBI_0000288>
    <rdfs:label xml:lang="en">amplification of a clone</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600063" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000257">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A DNA extraction is a nucleic acid extration where the desired output material is DNA.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">DNA extraction</OBI_0000288>
    <rdfs:label xml:lang="en">DNA extraction</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0666667" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000296">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">process of identifying a set of objects for further use in an investigation</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000287 xml:lang="en">Enrollment of patients in a study.</OBI_0000287>
    <OBI_0000288 xml:lang="en">enrollment</OBI_0000288>
    <rdfs:label xml:lang="en">enrollment</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600062" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500001">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Plan for the precise procedure to be followed in a clinical trial, including planned and actual timing of events, choice of control group, method of allocating treatments, blinding methods; assigns a subject to pass through one or more epochs in the course of a trial. Specific design elements, e.g., crossover, parallel; dose-escalation [Modified from Pocock, Clinical Trials: A Practical Approach]</OBI_0000291>
    <OBI_0000279 xml:lang="en">Clinical Research Glossary Version 4.0 CDICS glossary group</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000275 xml:lang="en">The definition needs to be extended to other things than simply patients</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">clinical study design</OBI_0000288>
    <rdfs:label xml:lang="en">clinical study design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000115" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500013">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000320"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">PRS to do</OBI_0000291>
    <OBI_0000279 xml:lang="en">Adapted from: http://www.itl.nist.gov/div898/handbook/pri/section3/pri3321.htm and</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000275 xml:lang="en">no example found in pubmed-&gt;not in use in the community</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">hyper graeco latin square design</OBI_0000288>
    <rdfs:label xml:lang="en">hyper graeco latin square design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500007" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500008">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000320"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">definition to be added</OBI_0000291>
    <OBI_0000279 xml:lang="en">http://en.wikipedia.org/wiki/Block_design</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 12933549</OBI_0000287>
    <OBI_0000288 xml:lang="en">balanced incomplete block design</OBI_0000288>
    <rdfs:label xml:lang="en">balanced incomplete block design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000115" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000045">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">not actively doing anything to a material for a duration of time.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Alan Ruttenberg</OBI_0000274>
    <OBI_0000275 xml:lang="en">BP: I have doubts about the utility of this.</OBI_0000275>
    <OBI_0000275 xml:lang="en">We need a better handling/modeling of time (January 2008)</OBI_0000275>
    <OBI_0000288 xml:lang="en">waiting</OBI_0000288>
    <rdfs:label xml:lang="en">waiting</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600009" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0300310">
    <OBI_0000291 xml:lang="en">Any design in which the decision as to whether to enroll the next patient, pair of patients, or block of patients is determined by whether the cumulative treatment difference for all previous patients is within specified limits.  Enrollment is continued if the difference does not exceed the limits.  It is terminated if it does</OBI_0000291>
    <OBI_0000279 xml:lang="en">MUSC</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">Provenance: OCI</OBI_0000275>
    <OBI_0000288 xml:lang="en">sequential design</OBI_0000288>
    <rdfs:label xml:lang="en">sequential design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000115" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600046">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of a biomaterial's preferential affinity for either the mobile phase or the stationary phase to separate it from other materials of differing affinity</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000275 xml:lang="en">Jay/Bjoern think this is problematic.  There are so many different types of chromatography.  This term may be overloaded.  May be best to define each type separately underneath material_separation.  Also, example seems to be an assay.</OBI_0000275>
    <OBI_0000287 xml:lang="en">The use of gas chromatography in order to identify the presence of pesticides in a sample of eggs</OBI_0000287>
    <OBI_0000288 xml:lang="en">chromatography</OBI_0000288>
    <rdfs:label xml:lang="en">chromatography</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000069">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A protocol application is a process carried out to bring about the \n    objective defined in the protocol applied. Every protocol_application has \n    one or more inputs and outputs definition_source: OBI.\na protocol_application is a planned process realizes a process in which the \n    objective of the protocol is achieved.\nThe manipulation of materials and information on materials as part of an investigation</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">rem1: This is an actual part of the experiment. It includes the protocol that the experimenter intends to carry out, deviations from this and unintended variables, such as the earthquake that occurred while the experiment was taking place.</OBI_0000275>
    <OBI_0000275 xml:lang="en">protocol_application part_of_process some sample_preparation_for_assay in obi before split (LF 040907)</OBI_0000275>
    <OBI_0000288 xml:lang="en">protocol application</OBI_0000288>
    <rdfs:label xml:lang="en">protocol application</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600062" />
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000308" />
        <owl:someValuesFrom>
          <owl:Restriction>
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000294" />
            <owl:someValuesFrom>
              <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000272" />
            </owl:someValuesFrom>
          </owl:Restriction>
        </owl:someValuesFrom>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600012">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">environmental_material_collection is an acquisition where an object is taken from an environment and put into a storage container. Roles include, environment, thing collected, container, acquirer.</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters, Alan Ruttenberg</OBI_0000274>
    <OBI_0000275 xml:lang="en">the researcher is very interested in the location</OBI_0000275>
    <OBI_0000287 xml:lang="en">Taking 1 liter of surface ocean water from the San Diego Mission Bay Jetty. Capturing mice living in rural Arkansas</OBI_0000287>
    <OBI_0000288 xml:lang="en">environmental material collection</OBI_0000288>
    <rdfs:label xml:lang="en">environmental material collection</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600008" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600027">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a material transformation to break the membranes of cells, releasing the cells contents; input=&gt;cells; output=&gt;cell_lysate</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">---\nThere is a more general 'membrane lysis', which could apply to artificial membranes etc. For this general membrane encapsulated objects would need to be defined.</OBI_0000275>
    <OBI_0000287 xml:lang="en">http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;db=PubMed&amp;amp;list_uids=16080188&amp;dopt=AbstractPlus; The destruction of cell membranes with detergent.</OBI_0000287>
    <OBI_0000288 xml:lang="en">cell membrane lysis</OBI_0000288>
    <rdfs:label xml:lang="en">cell membrane lysis</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000126" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600032">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to repair damaged DNA molecules</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">---\nis this really a protocol?\n--&gt; This as several other protocol applications is also a natural process. The fact that it is induced experimetnally by following a protocol makes it a protocol application. Need to make sure that labels don't conflict wi</OBI_0000275>
    <OBI_0000287 xml:lang="en">the use of DNA repair enzymes uracil DNA glycosylase and 3-methyladenine DNA glycosylase to repair DNA strands</OBI_0000287>
    <OBI_0000288 xml:lang="en">DNA repair</OBI_0000288>
    <rdfs:label xml:lang="en">DNA repair</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000126" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000171">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">is the transplantation of tissue from one part of \nthe body to another in the same individual. )</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">autotransplantation</OBI_0000288>
    <rdfs:label xml:lang="en">autotransplantation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000105" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000043">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">is the transplantation of living cells, tissues or \norgans from one species to another such as from pigs to humans</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">xenotransplantation</OBI_0000288>
    <rdfs:label xml:lang="en">xenotransplantation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000105" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600064">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">insertion of  a DNA fragment into a cloning vector which creates. Has input vectors + DNA fragments. Has output: recombinant vectors</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">pa_branch (Alan, Randi, Kevin, Jay, Bjoern)</OBI_0000274>
    <OBI_0000288 xml:lang="en">recombinant vector cloning</OBI_0000288>
    <rdfs:label xml:lang="en">recombinant vector cloning</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000035" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000231">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to digest the fraction of input material that is susceptible to that enzyme</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">enzymatic cleavage</OBI_0000288>
    <rdfs:label xml:lang="en">enzymatic cleavage</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500004">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">N-of-1 design is a cross-over design in which the same patient is repeatedly randomised to receive either the experimental treatment or its control (Senn, 1993).</OBI_0000291>
    <OBI_0000279 xml:lang="en">Adapted from  http://www.childrens-mercy.org/stats/definitions/crossover.htm and source:http://symptomresearch.nih.gov/chapter_6/sec1/csss1pg1.htm)</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">n-to-1 design</OBI_0000288>
    <rdfs:label xml:lang="en">n-to-1 design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500003" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600016">
    <OBI_0000286 xml:lang="en">sample pooling</OBI_0000286>
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">physical combination of several instances of like material</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000275 xml:lang="en">like' is one of the things that you should be controling for in a well-designed experiment. The instances of material need to have the same class.</OBI_0000275>
    <OBI_0000287 xml:lang="en">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=104564; Combining spleens of 20 mice, Combining supernatant from a cell culture obtained at different time points</OBI_0000287>
    <OBI_0000288 xml:lang="en">material pooling</OBI_0000288>
    <rdfs:label xml:lang="en">material pooling</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500027">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an inclusion rule (criterion) is_ rule*  in a protocol that prospective subjects must meet to be eligible for participation in a study</OBI_0000291>
    <OBI_0000279 xml:lang="en">Adapted from Clinical Research Glossary Version 4.0 CDICS glossary group</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17599746-RESULTS: Fifteen trials met our inclusion criteria. The summary effect size was 0.35 (95% confidence interval 0.14, 0.56). I(2) was 0.80.</OBI_0000287>
    <OBI_0000288 xml:lang="en">inclusion rule</OBI_0000288>
    <rdfs:label xml:lang="en">inclusion rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500026" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000227">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">is a process to encode an information entitiy into a digital document</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">We (protocol application branch) placed this term because it kept getting bounced from data transformation and DENRIE</OBI_0000275>
    <OBI_0000287 xml:lang="en">storage of measurement results from an assay into a text file, such as</OBI_0000287>
    <OBI_0000288 xml:lang="en">data encoding</OBI_0000288>
    <rdfs:label xml:lang="en">data encoding</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600062" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600021">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to preserve defined  qualities of cells or tissues (sample) which may otherwise change over time</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Bjoern Peters</OBI_0000274>
    <OBI_0000275 xml:lang="en">we could generalize this for other input materials</OBI_0000275>
    <OBI_0000275 xml:lang="en">should include capturing what qualities are being preserved</OBI_0000275>
    <OBI_0000287 xml:lang="en">http://www.tissuearray.org/CellLinesProtocolforTMA112.pdf; the treatment of CD8+ cells with methanol at -20oC; http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;db=PubMed&amp;amp;list_uids=16080188&amp;dopt=AbstractPlus</OBI_0000287>
    <OBI_0000288 xml:lang="en">cell fixation</OBI_0000288>
    <rdfs:label xml:lang="en">cell fixation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600028">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol to transcribe single-stranded RNA into complementary DNA (cDNA)</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of M-MLV reverse transcriptase from the Moloney murine leukemia virus to transcribe an RNA sample into cDNA</OBI_0000287>
    <OBI_0000288 xml:lang="en">reverse transcription</OBI_0000288>
    <rdfs:label xml:lang="en">reverse transcription</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000126" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600042">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the insertion of a particular gene into a plasmid in order to make copies of a biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The DNA fragment encoding the p35 gene from Mycobacterium avium complex was inserted into pcDNAII and expressed in E coli in order to study p35.</OBI_0000287>
    <OBI_0000288 xml:lang="en">recombinant plasmid cloning</OBI_0000288>
    <rdfs:label xml:lang="en">recombinant plasmid cloning</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000035" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600059">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of lysogenic infection to transfer DNA sequences into an organism</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The transfer of a recombinant bacterial plasmid into E.coli to facilitate amplification of a specific protein</OBI_0000287>
    <OBI_0000288 xml:lang="en">DNA transduction</OBI_0000288>
    <rdfs:label xml:lang="en">DNA transduction</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600043" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600052">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application that uses diffusiton through a semi-permeable membrane to separate an input material into two fractions of different composition</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">the use of a dialysis bag of select pore size to remove salt from collagen isolated from mouse cartilage</OBI_0000287>
    <OBI_0000288 xml:lang="en">dialysis</OBI_0000288>
    <rdfs:label xml:lang="en">dialysis</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600009">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an input material is exposed to a defined set of conditions in a controlled environment. The environment is an input of the protocol.</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000275 xml:lang="en">Alan says there will be problmes, e.g. with selection by survival</OBI_0000275>
    <OBI_0000287 xml:lang="en">Putting cells in a freezer at -80C.  Cy5-labeled DNA is irradiated with a laser to excite the fluorophore. Inducing a phase transition in a material by putting it in an environment with a specific temperature. Oxygen deprivation in a chamber.</OBI_0000287>
    <OBI_0000288 xml:lang="en">exposure of material to environment</OBI_0000288>
    <rdfs:label xml:lang="en">exposure of material to environment</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600026">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an assay in which the weight of an organism is measured over time</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">Alan says something is funny\n---\nThis is a description of what you did as opposed to the description of the assay. This should be more generic. something like 'mass_assay'\n</OBI_0000275>
    <OBI_0000287 xml:lang="en">The comparison of the weight of vaccinated and non-vaccinated mice after infection with influenza A over 6 weeks post-infection</OBI_0000287>
    <OBI_0000288 xml:lang="en">weight assessment</OBI_0000288>
    <rdfs:label xml:lang="en">weight assessment</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500020">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Groups of assays that are related as part of a time series.</OBI_0000291>
    <OBI_0000279 xml:lang="en">MO_887</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra on behalf of MO</OBI_0000274>
    <OBI_0000275 xml:lang="en">MO</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 14744830-Microarrays are powerful tools for surveying the expression levels of many thousands of genes simultaneously. They belong to the new genomics technologies which have important applications in the biological, agricultural and pharmaceutical sciences. There are myriad sources of uncertainty in microarray experiments, and rigorous experimental design is essential for fully realizing the potential of these valuable resources. Two questions frequently asked by biologists on the brink of conducting cDNA or two-colour, spotted microarray experiments are 'Which mRNA samples should be competitively hybridized together on the same slide?' and 'How many times should each slide be replicated?' Early experience has shown that whilst the field of classical experimental design has much to offer this emerging multi-disciplinary area, new approaches which accommodate features specific to the microarray context are needed. In this paper, we propose optimal designs for factorial and time course experiments, which are special designs arising quite frequently in microarray experimentation. Our criterion for optimality is statistical efficiency based on a new notion of admissible designs; our approach enables efficient designs to be selected subject to the information available on the effects of most interest to biologists, the number of arrays available for the experiment, and other resource or practical constraints, including limitations on the amount of mRNA probe. We show that our designs are superior to both the popular reference designs, which are highly inefficient, and to designs incorporating all possible direct pairwise comparisons. Moreover, our proposed designs represent a substantial practical improvement over classical experimental designs which work in terms of standard interactions and main effects. The latter do not provide a basis for meaningful inference on the effects of most interest to biologists, nor make the most efficient use of valuable and limited resources.</OBI_0000287>
    <OBI_0000288 xml:lang="en">time series design</OBI_0000288>
    <rdfs:label xml:lang="en">time series design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600051">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application that uses different concentrations of materials in a defined order to create a gradient to facilitate the separation of an input material into its components with specific qualities</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">the use of a sucrose gradient to isolate mitochondria</OBI_0000287>
    <OBI_0000288 xml:lang="en">gradient separation</OBI_0000288>
    <rdfs:label xml:lang="en">gradient separation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600005">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">is a protocol application in which material that is part of an organism is separated from the organism</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000287 xml:lang="en">taking a sputum sample from a cancer patient, taking the spleen from a killed mouse</OBI_0000287>
    <OBI_0000288 xml:lang="en">taking sample from organism</OBI_0000288>
    <rdfs:label xml:lang="en">taking sample from organism</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600015">
    <OBI_0000291 xml:lang="en">assigning objects to groups</OBI_0000291>
    <OBI_0000279 xml:lang="en">Philippe</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe</OBI_0000274>
    <OBI_0000287 xml:lang="en">splitting an enrolled population into a treated and controlled sub-group; randomized group assignment</OBI_0000287>
    <OBI_0000288 xml:lang="en">group assignment</OBI_0000288>
    <rdfs:label xml:lang="en">group assignment</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600062" />
  </owl:Class>
  <owl:Class rdf:about="http://www.geneontology.org/formats/oboInOwl#Class_2">
    <OBI_0000286 xml:lang="en">instruction</OBI_0000286>
    <OBI_0000291 xml:lang="en">is the specification of a process that can be concretized and realized by an actor</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000288 xml:lang="en">realizable-information entity</OBI_0000288>
    <rdfs:label xml:lang="en">realizable-information entity</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.geneontology.org/formats/oboInOwl#Class_1" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000344">
    <OBI_0000291 xml:lang="en">a plan is a specification of a process that is realized by an actor to \n    achieve the objective specified as part of the plan</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">Part of range for an object property is_potentially_realizable_as in obi before split (LF 040907)</OBI_0000275>
    <OBI_0000288 xml:lang="en">plan</OBI_0000288>
    <rdfs:label xml:lang="en">plan</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.geneontology.org/formats/oboInOwl#Class_2" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500010">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A reference experiment design type is where all samples are compared to a common reference.</OBI_0000291>
    <OBI_0000279 xml:lang="en">MO_699</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra on behalf of MO</OBI_0000274>
    <OBI_0000275 xml:lang="en">MO</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 12933549</OBI_0000287>
    <OBI_0000288 xml:lang="en">reference design</OBI_0000288>
    <rdfs:label xml:lang="en">reference design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600038">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the addition of a labeling reagent to an input biomaterial in order to detect the labeled material in the future</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000275 xml:lang="en">definition blessed by Allyson, Bjoern, Jay &amp; Randi</OBI_0000275>
    <OBI_0000287 xml:lang="en">The addition of phycoerytherin label to an anti-CD8 antibody, to label all antibodies. The addition of anti-CD8-PE to a population of cells, to label the subpopulation cells that are CD8+.</OBI_0000287>
    <OBI_0000288 xml:lang="en">labeling</OBI_0000288>
    <rdfs:label xml:lang="en">labeling</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000356">
    <OBI_0000291 xml:lang="en">is an investigation in which data is generated and analyzed with the purpose of generating new hypothesis</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">hypothesis generating investigation</OBI_0000288>
    <rdfs:label xml:lang="en">hypothesis generating investigation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000066" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500026">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an eligibility rule (criterion) is_a *rule* which defines the positive and negative criteria decide an entity to enter a study and that will define the population of the study</OBI_0000291>
    <OBI_0000279 xml:lang="en">Adapted from Clinical Research Glossary Version 4.0 CDICS glossary group</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17579629 -Eligibility criteria included: untreated ED-SCLC; age &gt;/=70 and performance status 0-2, or age &lt;70 and PS 3.</OBI_0000287>
    <OBI_0000288 xml:lang="en">eligibility rule</OBI_0000288>
    <rdfs:label xml:lang="en">eligibility rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500021" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600010">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an object acquisition is an acquisition of an object from an investigator, institution or vendor. Participant roles include source, destination, carrier, container, transaction record, payer...</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters, Alan Ruttenberg</OBI_0000274>
    <OBI_0000275 xml:lang="en">Bjoern is concerned that information such as model number and serial number are to be associated with the process. Others contend that these are associated, perhaps as labels, to the instances that are the participants.</OBI_0000275>
    <OBI_0000287 xml:lang="en">Acquiring 50 C57BL/6 mice in the investigators animal facilities. Purchasing 1 mg of peptides synthesized by Mimotopes at 80% purity. Getting a gift of purified CD4+ specific antibodies presented by Stephen Schoenberger at LIAI.</OBI_0000287>
    <OBI_0000288 xml:lang="en">object acquisition</OBI_0000288>
    <rdfs:label xml:lang="en">object acquisition</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600008" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500017">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">An experiment design type where the label orientations are reversed. exact synonym: flip dye, dye flip</OBI_0000291>
    <OBI_0000279 xml:lang="en">MO_858</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra on behalf of MO</OBI_0000274>
    <OBI_0000275 xml:lang="en">MO</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17411393-Dye-specific bias effects, commonly observed in the two-color microarray platform, are normally corrected using the dye swap design. This design, however, is relatively expensive and labor-intensive. We propose a self-self hybridization design as an alternative to the dye swap design. In this design, the treated and control samples are labeled with Cy5 and Cy3 (or Cy3 and Cy5), respectively, without dye swap, along with a set of self-self hybridizations on the control sample. We compare this design with the dye swap design through investigation of mouse primary hepatocytes treated with three peroxisome proliferator-activated receptor-alpha (PPARalpha) agonists at three dose levels. Using Agilent's Whole Mouse Genome microarray, differentially expressed genes (DEG) were determined for both the self-self hybridization and dye swap designs. The DEG concordance between the two designs was over 80% across each dose treatment and chemical. Furthermore, 90% of DEG-associated biological pathways were in common between the designs, indicating that biological interpretations would be consistent. The reduced labor and expense for the self-self hybridization design make it an efficient substitute for the dye swap design. For example, in larger toxicogenomic studies, only about half the chips are required for the self-self hybridization design compared to that needed in the dye swap design.</OBI_0000287>
    <OBI_0000288 xml:lang="en">dye swap design</OBI_0000288>
    <rdfs:label xml:lang="en">dye swap design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600024">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application in which cells are kept alive in a defined environment outside of an organism.  part of cell_culturing</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000287 xml:lang="en">When harvesting blood from a human, isolating T cells, and then limited dilution cloning of the cells, the maintaining_cell_culture step comprises all steps after the initial dilution and plating of the cells into culture, e.g. placing the culture into an incubator, changing or adding media, and splitting a cell culture</OBI_0000287>
    <OBI_0000288 xml:lang="en">maintaining cell culture</OBI_0000288>
    <rdfs:label xml:lang="en">maintaining cell culture</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600030">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to induce a specific disease in an organism</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">could be defined class</OBI_0000275>
    <OBI_0000287 xml:lang="en">the injection of mice with LCM virus iv to establish an LCMV infection. Witholding food from animals to induce starvation syndrome.</OBI_0000287>
    <OBI_0000288 xml:lang="en">experimental disease induction</OBI_0000288>
    <rdfs:label xml:lang="en">experimental disease induction</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500021">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a rule is an executable which guides, defines, restricts actions</OBI_0000291>
    <OBI_0000279 xml:lang="en">PRS</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">rule</OBI_0000288>
    <rdfs:label xml:lang="en">rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000349" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600036">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">creating an in vitro environment in which cells are sustained from input material containing cells. input: cell-containing material, output cell culture, part of cell culturing. Cells are originally plated at a certain concentration referred to as seeding density.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000287 xml:lang="en">When harvesting blood from a human, isolating T cells, and then limited dilution cloning of the cells, the establishing_cell_culture step comprises preparing the cells at a certain dilution and plating them in a container with growth medium.</OBI_0000287>
    <OBI_0000288 xml:lang="en">establishing cell culture</OBI_0000288>
    <rdfs:label xml:lang="en">establishing cell culture</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://www.geneontology.org/formats/oboInOwl#Class_1">
    <OBI_0000291 xml:lang="en">A specification is an information entity, which can be used to classify entities into conforming or non-conforming in respect to the specification</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000288 xml:lang="en">specification</OBI_0000288>
    <rdfs:label xml:lang="en">specification</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000080" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600019">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">The addition of a reagent labeling the entire input biomaterial enabling future detection of the output biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">definition blessed by Allyson, Bjoern, Jay &amp; Randi</OBI_0000275>
    <OBI_0000287 xml:lang="en">The addition of phycoerytherin label to an anti-CD8 antibody, to label all antibodies.</OBI_0000287>
    <OBI_0000288 xml:lang="en">non-specific labeling</OBI_0000288>
    <rdfs:label xml:lang="en">non-specific labeling</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600038" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500019">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A self vs. self experiment design investigates variance and error estimates in the experimental system, and is where the same extract is compared.</OBI_0000291>
    <OBI_0000279 xml:lang="en">MO_490</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra on behalf of MO</OBI_0000274>
    <OBI_0000275 xml:lang="en">MO</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17411393-Dye-specific bias effects, commonly observed in the two-color microarray platform, are normally corrected using the dye swap design. This design, however, is relatively expensive and labor-intensive. We propose a self-self hybridization design as an alternative to the dye swap design. In this design, the treated and control samples are labeled with Cy5 and Cy3 (or Cy3 and Cy5), respectively, without dye swap, along with a set of self-self hybridizations on the control sample. We compare this design with the dye swap design through investigation of mouse primary hepatocytes treated with three peroxisome proliferator-activated receptor-alpha (PPARalpha) agonists at three dose levels. Using Agilent's Whole Mouse Genome microarray, differentially expressed genes (DEG) were determined for both the self-self hybridization and dye swap designs. The DEG concordance between the two designs was over 80% across each dose treatment and chemical. Furthermore, 90% of DEG-associated biological pathways were in common between the designs, indicating that biological interpretations would be consistent. The reduced labor and expense for the self-self hybridization design make it an efficient substitute for the dye swap design. For example, in larger toxicogenomic studies, only about half the chips are required for the self-self hybridization design compared to that needed in the dye swap design.</OBI_0000287>
    <OBI_0000288 xml:lang="en">self vs self design</OBI_0000288>
    <rdfs:label xml:lang="en">self vs self design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500005">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A matched pair design is a study design which use groups of individuals associated (hence matched) to each other based on a set of criteria, one member going to one treatment, the other member receiving the other treatment.</OBI_0000291>
    <OBI_0000279 xml:lang="en">http://www.holah.karoo.net/experimentaldesigns.htm</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17288613-BSTRACT: BACKGROUND: Physicians in Canadian emergency departments (EDs) annually treat 185,000 alert and stable trauma victims who are at risk for cervical spine (C-spine) injury. However, only 0.9% of these patients have suffered a cervical spine fracture. Current use of radiography is not efficient. The Canadian C-Spine Rule is designed to allow physicians to be more selective and accurate in ordering C-spine radiography, and to rapidly clear the C-spine without the need for radiography in many patients. The goal of this phase III study is to evaluate the effectiveness of an active strategy to implement the Canadian C-Spine Rule into physician practice. Specific objectives are to: 1) determine clinical impact, 2) determine sustainability, 3) evaluate performance, and 4) conduct an economic evaluation. METHODS: We propose a matched-pair cluster design study that compares outcomes during three consecutive 12-months before, after, and decay periods at six pairs of intervention and control sites. These 12 hospital ED sites will be stratified as teaching or community hospitals, matched according to baseline C-spine radiography ordering rates, and then allocated within each pair to either intervention or control groups. During the after period at the intervention sites, simple and inexpensive strategies will be employed to actively implement the Canadian C-Spine Rule. The following outcomes will be assessed: 1) measures of clinical impact, 2) performance of the Canadian C-Spine Rule, and 3) economic measures. During the 12-month decay period, implementation strategies will continue, allowing us to evaluate the sustainability of the effect. We estimate a sample size of 4,800 patients in each period in order to have adequate power to evaluate the main outcomes. DISCUSSION: Phase I successfully derived the Canadian C-Spine Rule and phase II confirmed the accuracy and safety of the rule, hence, the potential for physicians to improve care. What remains unknown is the actual change in clinical behaviors that can be affected by implementation of the Canadian C-Spine Rule, and whether implementation can be achieved with simple and inexpensive measures. We believe that the Canadian C-Spine Rule has the potential to significantly reduce health care costs and improve the efficiency of patient flow in busy Canadian EDs.</OBI_0000287>
    <OBI_0000288 xml:lang="en">matched pairs design</OBI_0000288>
    <rdfs:label xml:lang="en">matched pairs design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600025">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">any protocol which results in the detection of a specified substance</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">the detection of phycoerytherin by means of flow cytometry</OBI_0000287>
    <OBI_0000288 xml:lang="en">substance detection</OBI_0000288>
    <rdfs:label xml:lang="en">substance detection</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600063">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">is the generation of copies of biomaterial by in a cell_culture modified for this purpose by insertion of an expression vectors</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">needs defined relationship to cell culture</OBI_0000275>
    <OBI_0000288 xml:lang="en">cell growth mediated amplification</OBI_0000288>
    <rdfs:label xml:lang="en">cell growth mediated amplification</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000035" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500025">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an ethical standard compliance rule is_a *compliance rule* which enable a  *ethical compliance process* to occur</OBI_0000291>
    <OBI_0000279 xml:lang="en">PRS</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">ethical standard compliance rule</OBI_0000288>
    <rdfs:label xml:lang="en">ethical standard compliance rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500024" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000153">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A material combination in which cell cultures of two or more different types are are combined and allowed to culture as one.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000287 xml:lang="en">Culturing  cytotoxic T-lymphocytes together with target cells in order to study lysis of the target cells. See chromium_release_assay</OBI_0000287>
    <OBI_0000288 xml:lang="en">cell co-culturing</OBI_0000288>
    <rdfs:label xml:lang="en">cell co-culturing</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
    <rdfs:subClassOf>
      <owl:Class>
        <owl:intersectionOf rdf:parseType="Collection">
          <owl:Restriction>
            <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2</owl:minCardinality>
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000293" />
          </owl:Restriction>
          <owl:Restriction>
            <owl:allValuesFrom rdf:resource="http://purl.org/obo/owl/CL#CL_0000000" />
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000293" />
          </owl:Restriction>
        </owl:intersectionOf>
      </owl:Class>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500028">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an exclusion rule (criterion) is_a *eligibility rule*  prospective subjects should not meet to be eligible for participation in a study</OBI_0000291>
    <OBI_0000279 xml:lang="en">Adapted from Clinical Research Glossary Version 4.0 CDICS glossary group</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17600285-Exclusion criteria included the use of any topical ophthalmic or topical oral medication and/or history of ocular or oral surgery within the past six months.</OBI_0000287>
    <OBI_0000288 xml:lang="en">exclusion rule</OBI_0000288>
    <rdfs:label xml:lang="en">exclusion rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500026" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600049">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of a DNA polymerase to make copies of a biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of taq polymerase to amplify a DNA fragment during a PCR.</OBI_0000287>
    <OBI_0000288 xml:lang="en">DNA polymerase amplification</OBI_0000288>
    <rdfs:label xml:lang="en">DNA polymerase amplification</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600058" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600062">
    <OBI_0000291 xml:lang="en">is a process that is the realization of some plan</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000275 xml:lang="en">several roles are implied in this: There must be one or more actors that realizes the plan, potentially a planner that devised the plan, potentially a supervisor monitoring the plan.</OBI_0000275>
    <OBI_0000288 xml:lang="en">planned process</OBI_0000288>
    <rdfs:label xml:lang="en">planned process</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.ifomis.org/bfo/1.1/span#Process" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500009">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A loop experiment design is where labeled extracts are compared in consecutive pairs. synonym: circular design</OBI_0000291>
    <OBI_0000279 xml:lang="en">MO_912</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra on behalf of MO</OBI_0000274>
    <OBI_0000275 xml:lang="en">MO</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 12933549</OBI_0000287>
    <OBI_0000288 xml:lang="en">loop design</OBI_0000288>
    <rdfs:label xml:lang="en">loop design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600029">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol which results in the separation of supernatant material from a cell culture</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">This does not apply to the case where the cells are lysed</OBI_0000275>
    <OBI_0000287 xml:lang="en">Pouring out a portion of the fluid part of an adherant cell culture growing in a flask.; The centrifugation of a T cell culture followed by aspiration of the supernatant while the cellular pellet remains in the centrifuge tube.</OBI_0000287>
    <OBI_0000288 xml:lang="en">isolation of cell culture supernatant</OBI_0000288>
    <rdfs:label xml:lang="en">isolation of cell culture supernatant</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600067">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a labeling in which the labeling reagent used  has a specificity to bind only certain components of the input material</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">definition blessed by Allyson, Bjoern, Jay &amp; Randi</OBI_0000275>
    <OBI_0000287 xml:lang="en">The addition of anti-CD8 antibody for an ICCS assay in order to selectively stain the CD8+ cells</OBI_0000287>
    <OBI_0000288 xml:lang="en">specific labeling</OBI_0000288>
    <rdfs:label xml:lang="en">specific labeling</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600038" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600008">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the process of obtaining a continuant from a source.</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000288 xml:lang="en">acquisition</OBI_0000288>
    <rdfs:label xml:lang="en">acquisition</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600062" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000070">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">An assay is a protocol application which includes evaluant (evaluant term \n    definition to be added by Richard, currently under role) as an input  and \n    which objective is to generate output data about qualities or other \n    features on the input material [Action Item for Barry to refine \n    definition] definition_source: OBI.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">AltDef: An assay is a protocol application which is a process of measuring. rem1: Imaging is covered by this definition. rem2: material:  used in the context of studying some biological problem, example: hybridization</OBI_0000275>
    <OBI_0000275 xml:lang="en">proposal to group the assays by what is the data gathered: detection of material (analyte), measurement of material quality (radioactivity), identification of material, measurement of process (</OBI_0000275>
    <OBI_0000288 xml:lang="en">assay</OBI_0000288>
    <rdfs:label xml:lang="en">assay</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000069" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000057">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">is the transplantation of organs between members of \nthe same species.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">allotransplantation</OBI_0000288>
    <rdfs:label xml:lang="en">allotransplantation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000105" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600007">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a substance is intentionally given to an organism through a specified route of administration</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000275 xml:lang="en">needs roles such as perturber and perturbee (children of input role). Perturb is too strong. Host might be the name for one role. Others considered: Doner, Donated, Acceptor.</OBI_0000275>
    <OBI_0000275 xml:lang="en">Different routes and means of administration should go as children underneath this</OBI_0000275>
    <OBI_0000287 xml:lang="en">injecting mice with 10 ug morphine intranasally, a patient taking two pills of 1 mg aspirin orally</OBI_0000287>
    <OBI_0000288 xml:lang="en">administering substance in vivo</OBI_0000288>
    <rdfs:label xml:lang="en">administering substance in vivo</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500007">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A randomized complete block design is_a study design which assigns randomly treatments to block. The number of units per block equals the number of treatment so each block receives each treatment exactly once (hence the qualifier 'complete'). The design was originally devised from field trials used in agronomy and agriculture. The analysis assumes that there is no interaction between block and treatment. The method was then used in other settings So The randomised complete block design is a design in which the subjects are matched according to a variable which the experimenter wishes to control. The subjects are put into groups (blocks) of the same size as the number of treatments. The members of each block are then randomly assigned to different treatment groups.</OBI_0000291>
    <OBI_0000279 xml:lang="en">http://www.tufts.edu/~gdallal/ranblock.htm</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">http://www.stats.gla.ac.uk/steps/glossary/anova.html,(A researcher is carrying out a study of the effectiveness of four different skin creams for the treatment of a certain skin disease. He has eighty subjects and plans to divide them into 4 treatment groups of twenty subjects each. Using a randomised blocks&amp; design, the subjects are assessed and put in blocks of four according to how severe their skin condition is; the four most severe cases are the first block, the next four most severe cases are the second block, and so on to the twentieth block. The four &amp;members of each block are then randomly assigned, one to each of the four treatment groups. http://www.stats.gla.ac.uk/steps/glossary/anova.html#rbd))</OBI_0000287>
    <OBI_0000288 xml:lang="en">randomized complete block design</OBI_0000288>
    <rdfs:label xml:lang="en">randomized complete block design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000115" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000080">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">BFO to do</OBI_0000291>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">information entity</OBI_0000288>
    <rdfs:label xml:lang="en">information entity</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000253">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Is a material transformation in which strands of nucleic acids that are (somewhat) complementary form a double-stranded molecule. Has input at least two single stranded molecules of nucleic acid molecules.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000287 xml:lang="en">www.ornl.gov/sci/techresources/Human_Genome/publicat/97pr/09gloss.html, http://www.accessexcellence.org/RC/VL/GG/nucleic.html, http://omrf.ouhsc.edu/~frank/HYBNOTES.html. http://en.wikipedia.org/wiki/Nucleic_acid_hybridization,http://www.pnas.org/cgi/reprint/46/8/1044.pdf</OBI_0000287>
    <OBI_0000288 xml:lang="en">nucleic acid hybridization</OBI_0000288>
    <rdfs:label xml:lang="en">nucleic acid hybridization</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000126" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600060">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of physical, electrical and chemical phenomena to introduce DNA into a cell</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of electroporation to permeabilize a cell membrane in order to introduce a plasmid encoding for a labeled protein of interest</OBI_0000287>
    <OBI_0000288 xml:lang="en">DNA transfection</OBI_0000288>
    <rdfs:label xml:lang="en">DNA transfection</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600043" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000331">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">revisit?</OBI_0000291>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">time trigger</OBI_0000288>
    <rdfs:label xml:lang="en">time trigger</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000349" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600023">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to digest the fraction of input material that is susceptible to that enzyme</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of agarase to digest an agar gel</OBI_0000287>
    <OBI_0000288 xml:lang="en">non specific enzymatic cleavage</OBI_0000288>
    <rdfs:label xml:lang="en">non specific enzymatic cleavage</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000231" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600065">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Place holder class, see editor note</OBI_0000291>
    <OBI_0000275 xml:lang="en">junk class to gather the defined classes</OBI_0000275>
    <OBI_0000288 xml:lang="en">_defined protocol application</OBI_0000288>
    <rdfs:label xml:lang="en">_defined protocol application</rdfs:label>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500003">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a cross-over design is a study design which ensures that experimental units receive, in sequence, the treatment (or the control), and then, after a specified time interval (aka *wash-out periods*), switch to the control (or treatment). In this design, subjects (patients in human context) serve as their own controls, and randomization may be used to determine the ordering which a subject receives the treatment and control</OBI_0000291>
    <OBI_0000279 xml:lang="en">(source: http://www.sbu.se/Filer/Content0/publikationer/1/literaturesearching_1993/glossary.html)</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000275 xml:lang="en">Replace patient or subject (keep track of this in the definition): DONE</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17601993-Objective: HIV-infected patients with lipodystrophy (HIV-lipodystrophy) are insulin resistant and have elevated plasma free fatty acid (FFA) concentrations. We aimed to explore the mechanisms underlying FFA-induced insulin resistance in patients with HIV-lipodystrophy. Research Design and Methods: Using a randomized placebo-controlled cross-over design, we studied the effects of an overnight acipimox-induced suppression of FFA on glucose and FFA metabolism by using stable isotope labelled tracer techniques during basal conditions and a two-stage euglycemic, hyperinsulinemic clamp (20 mU insulin/m(2)/min; 50 mU insulin/m(2)/min) in nine patients with nondiabetic HIV-lipodystrophy. All patients received antiretroviral therapy. Biopsies from the vastus lateralis muscle were obtained during each stage of the clamp. Results: Acipimox treatment reduced basal FFA rate of appearance by 68.9% (52.6%-79.5%) and decreased plasma FFA concentration by 51.6 % (42.0%-58.9%), (both, P &lt; 0.0001). Endogenous glucose production was not influenced by acipimox. During the clamp the increase in glucose-uptake was significantly greater after acipimox treatment compared to placebo (acipimox: 26.85 (18.09-39.86) vs placebo: 20.30 (13.67-30.13) mumol/kg/min; P &lt; 0.01). Insulin increased phosphorylation of Akt (Thr(308)) and GSK-3beta (Ser(9)), decreased phosphorylation of glycogen synthase (GS) site 3a+b and increased GS-activity (I-form) in skeletal muscle (P &lt; 0.01). Acipimox decreased phosphorylation of GS (site 3a+b) (P &lt; 0.02) and increased GS-activity (P &lt; 0.01) in muscle. Conclusion: The present study provides direct evidence that suppression of lipolysis in patients with HIV-lipodystrophy improves insulin-stimulated peripheral glucose-uptake. The increased glucose-uptake may in part be explained by increased dephosphorylation of GS (site 3a+b) resulting in increased GS activity.</OBI_0000287>
    <OBI_0000288 xml:lang="en">cross over design</OBI_0000288>
    <rdfs:label xml:lang="en">cross over design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500002" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600000">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">material combination where one of the input materials is a cell culture and another material is not a cell culture</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000287 xml:lang="en">adding fetal calf serum to a 96 well plate containing a cell culture derived from a blood sample of a patient</OBI_0000287>
    <OBI_0000288 xml:lang="en">administering substance to cell culture</OBI_0000288>
    <rdfs:label xml:lang="en">administering substance to cell culture</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600002">
    <OBI_0000286 xml:lang="en">grading of tumor</OBI_0000286>
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Determination of the grade (severity/stage)  of a tumor sample, used in cancer biology to describe abnormalities/qualities of tumor cells or tissues.Values can be described by terms from NCI Thesaurus.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived; submitted by MO</OBI_0000279>
    <OBI_0000274 xml:lang="en">Compiled by Helen Parkinson for Transcriptomics thanks to Adam Witney</OBI_0000274>
    <OBI_0000288 xml:lang="en">tumor grading</OBI_0000288>
    <rdfs:label xml:lang="en">tumor grading</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500011">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Latin square design is_a study design which allows in its simpler form controlling 2 levels of nuisance variables (also known as blocking variables).he 2 nuisance factors are divided into a tabular grid with the property that each row and each column receive each treatment exactly once.</OBI_0000291>
    <OBI_0000279 xml:lang="en">Adapted from: http://www.itl.nist.gov/div898/handbook/pri/section3/pri3321.htm and</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17582121-Our objective was to examine the effects of dietary cation-anion difference (DCAD) with different concentrations of dietary crude protein (CP) on performance and acid-base status in early lactation cows. Six lactating Holstein cows averaging 44 d in milk were used in a 6 x 6 Latin square design with a 2 x 3 factorial arrangement of treatments: DCAD of -3, 22, or 47 milliequivalents (Na + K - Cl - S)/100 g of dry matter (DM), and 16 or 19% CP on a DM basis. Linear increases with DCAD occurred in DM intake, milk fat percentage, 4% fat-corrected milk production, milk true protein, milk lactose, and milk solids-not-fat. Milk production itself was unaffected by DCAD. Jugular venous blood pH, base excess and HCO3(-) concentration, and urine pH increased, but jugular venous blood Cl- concentration, urine titratable acidity, and net acid excretion decreased linearly with increasing DCAD. An elevated ratio of coccygeal venous plasma essential AA to nonessential AA with increasing DCAD indicated that N metabolism in the rumen was affected, probably resulting in more microbial protein flowing to the small intestine. Cows fed 16% CP had lower urea N in milk than cows fed 19% CP; the same was true for urea N in coccygeal venous plasma and urine. Dry matter intake, milk production, milk composition, and acid-base status did not differ between the 16 and 19% CP treatments. It was concluded that DCAD affected DM intake and performance of dairy cows in early lactation. Feeding 16% dietary CP to cows in early lactation, compared with 19% CP, maintained lactation performance while reducing urea N excretion in milk and urine.</OBI_0000287>
    <OBI_0000288 xml:lang="en">latin square design</OBI_0000288>
    <rdfs:label xml:lang="en">latin square design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500007" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000126">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Place holder class, see editor note</OBI_0000291>
    <OBI_0000275 xml:lang="en">This is a placeholder class to collect all protocl applications where the name conflicts with natural processes that could be classes in other ontologies. The fact that it is induced experimetnally by following a protocol makes it a protocol application. Need to make sure that labels don't conflict with natural processes.\nThe terms: translation and transcription were also requested.</OBI_0000275>
    <OBI_0000288 xml:lang="en">_induction of natural processes</OBI_0000288>
    <rdfs:label xml:lang="en">_induction of natural processes</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600055">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of enzymes to cut DNA molecules, the study of DNA through cleavage, mapping, and analysis of the fragments</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">the use of the restriction enzymes SalPI and PstI to cleave DNA into fragments, assay made up of components</OBI_0000287>
    <OBI_0000288 xml:lang="en">DNA cleavage, restriction analysis</OBI_0000288>
    <rdfs:label xml:lang="en">DNA cleavage, restriction analysis</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000231" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600033">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A protocol application to permeabilize cell membranes, allowing molecules to more easily pass through the membrane than was possible prior to the protocol application</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Bjoern Peters</OBI_0000274>
    <OBI_0000275 xml:lang="en">definition blessed by Jay, Alan, Randi</OBI_0000275>
    <OBI_0000287 xml:lang="en">Electroporation of HeLa cells to allow transfection with pUC19.</OBI_0000287>
    <OBI_0000288 xml:lang="en">cell permeabalization</OBI_0000288>
    <rdfs:label xml:lang="en">cell permeabalization</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000182">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A nuclear magnetic resonance assay is an assay used to identify the chemical structure of a compound or biological macromolecule. definition_source: www.nature.com/nrd/journal/v2/n5/glossary/nrd1086_glossary.html</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">nuclear magnetic resonance assay</OBI_0000288>
    <rdfs:label xml:lang="en">nuclear magnetic resonance assay</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600040">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the construction of a biomaterial from simpler biomaterials</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000275 xml:lang="en">This probably needs breaking down into more specific applications. The example given is already covered in reverse_transcription</OBI_0000275>
    <OBI_0000287 xml:lang="en">making cDNA from nucleotides using RNA as a template</OBI_0000287>
    <OBI_0000288 xml:lang="en">synthesize</OBI_0000288>
    <rdfs:label xml:lang="en">synthesize</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600058">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of enzymes to increase the number of molecules of a biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">the use of a polymerase chain reaction to amplify a fragment of DNA</OBI_0000287>
    <OBI_0000288 xml:lang="en">enzymatic amplification</OBI_0000288>
    <rdfs:label xml:lang="en">enzymatic amplification</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600053">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application that uses an electrical potential to move material through a defined matrix in order to separate it by its resistance to movement and its charge</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000275 xml:lang="en">Need to define more terms like gel_separation, matrix,centrifugation, and the connection between the force used to separate materials and the medium or barriers.</OBI_0000275>
    <OBI_0000287 xml:lang="en">Loading a mixture of proteins into a polyacrylamide gel and the application of an electrical current to the gel to separate the proteins by size and change.</OBI_0000287>
    <OBI_0000288 xml:lang="en">electrophoresis</OBI_0000288>
    <rdfs:label xml:lang="en">electrophoresis</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000185">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">An imaging assay is an assay to produce a picture of an entity. definition_source: OBI.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">imaging assay</OBI_0000288>
    <rdfs:label xml:lang="en">imaging assay</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600050">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to digest the fraction of input material that is susceptible to that enzyme</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of a protease to digest a protein into peptides</OBI_0000287>
    <OBI_0000288 xml:lang="en">specific enzymatic cleavage</OBI_0000288>
    <rdfs:label xml:lang="en">specific enzymatic cleavage</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000231" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600022">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use physical means to remove a portion of a substance from the rest</OBI_0000291>
    <OBI_0000279 xml:lang="en">www.crohnsresource.com/glossary.jsp (via google define:resection)</OBI_0000279>
    <OBI_0000274 xml:lang="en">Alan Ruttenberg, Kevin Clancy</OBI_0000274>
    <OBI_0000275 xml:lang="en">BP: duplicate rdfs:label entry, en</OBI_0000275>
    <OBI_0000287 xml:lang="en">Cutting out the portion of a gel which contains a DNA fragment</OBI_0000287>
    <OBI_0000288 xml:lang="en">excision</OBI_0000288>
    <rdfs:label xml:lang="en">excision</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600017">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the detection of the amount of a label which is a proxy for the detection of the labeled biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Bjoern Peters</OBI_0000274>
    <OBI_0000287 xml:lang="en">Determination of the amount of phycoerytherin label present in a cell population stained with anti-CD8-PE in order to determine the percentage of CD8+ T cells present</OBI_0000287>
    <OBI_0000288 xml:lang="en">detection of label</OBI_0000288>
    <rdfs:label xml:lang="en">detection of label</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500012">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Greco-Latin square design is a study design which relates to Latin square design</OBI_0000291>
    <OBI_0000279 xml:lang="en">Adapted from: http://www.itl.nist.gov/div898/handbook/pri/section3/pri3321.htm and</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000275 xml:lang="en">only 2 articles in pubmed -&gt;probably irrelevant</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 6846242-Beaton et al (Am J Clin Nutr 1979;32:2546-59) reported on the partitioning of variance in 1-day dietary data for the intake of energy, protein, total carbohydrate, total fat, classes of fatty acids, cholesterol, and alcohol. Using the same food intake data and the expanded National Heart, Lung and Blood Institute food composition data base, these analyses of sources of variance have been expanded to include classes of carbohydrate, vitamin A, vitamin C, thiamin, riboflavin, niacin, calcium, iron, total ash, caffeine, and crude fiber. The analyses relate to observed intakes (replicated six times) of 30 adult males and 30 adult females obtained under a paired Graeco-Latin square design with sequence of interview, interviewer, and day of the week as determinants. Neither sequence nor interviewer made consistent contribution to variance. In females, day of the week had a significant effect for several nutrients. The major partitioning of variance was between interindividual variation (between subjects) and intraindividual variation (within subjects) which included both true day-to-day variation in intake and methodological variation. For all except caffeine, the intraindividual variability of 1-day data was larger than the interindividual variability. For vitamin A, almost all of the variance was associated with day-to-day variability. One day data provide a very inadequate estimate of usual intake of individuals. In the design of nutrition studies it is critical that the intended use of dietary data be a major consideration in deciding on methodology. There is no ideal dietary method. There may be preferred methods for particular purposes.</OBI_0000287>
    <OBI_0000288 xml:lang="en">graeco latin square design</OBI_0000288>
    <rdfs:label xml:lang="en">graeco latin square design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500007" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600011">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A protocol application in which an object is left in an environment for some period of time, until some qualities of interest are in equilibrium with that environment.</OBI_0000291>
    <OBI_0000279 xml:lang="en">CEBS, Biomaterial_branch</OBI_0000279>
    <OBI_0000274 xml:lang="en">Jennifer Fostel</OBI_0000274>
    <OBI_0000287 xml:lang="en">placing mice in animal facility for 2 weeks prior to an experiment to accustom them to their environment, reducing stress</OBI_0000287>
    <OBI_0000288 xml:lang="en">acclimatization</OBI_0000288>
    <rdfs:label xml:lang="en">acclimatization</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600009" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600006">
    <OBI_0000286 xml:lang="en">death status type</OBI_0000286>
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A protocol application in which an organism is intentionally put to death</OBI_0000291>
    <OBI_0000279 xml:lang="en">CEBS, Biomaterial_branch</OBI_0000279>
    <OBI_0000274 xml:lang="en">Jennifer Fostel</OBI_0000274>
    <OBI_0000275 xml:lang="en">difficult to place this properly - JG. Death process (e.g. unscheduled death) is out of scope but should be added somewhere. All killings have death process as a part, but not all death processes are part of a killing.</OBI_0000275>
    <OBI_0000287 xml:lang="en">Terminal sacrifice of animals by cervical dislocation at the end of an investigation.</OBI_0000287>
    <OBI_0000288 xml:lang="en">killing</OBI_0000288>
    <rdfs:label xml:lang="en">killing</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600031">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">an assay in which the number of cells producing a biomaterial in a larger cell population are stained and counted</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">\n---\nThis term conflates several things. Everytime you stain a population of cells and count them this is NOT an ELISPOT assay. We need assay terms to describe the staining of things that are cells, and a counting of things that are cells. We need to work out what make an ELISPOT assay different from staining and counting cells\n</OBI_0000275>
    <OBI_0000287 xml:lang="en">Determination of the frequency of cells producing IFN-gamma in response to viral peptides</OBI_0000287>
    <OBI_0000288 xml:lang="en">ELISPOT</OBI_0000288>
    <rdfs:label xml:lang="en">ELISPOT</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0300311">
    <OBI_0000291 xml:lang="en">observation design is a study design in which subjects are monitored in the absence of any active intervention by experimentalists.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000288 xml:lang="en">observation design</OBI_0000288>
    <rdfs:label xml:lang="en">observation design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600057">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of enzymes to duplicate DNA moleculeany process used to make additional copies of a biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">the use of enzymes to duplicate DNA molecules</OBI_0000287>
    <OBI_0000288 xml:lang="en">enzymatic DNA replication</OBI_0000288>
    <rdfs:label xml:lang="en">enzymatic DNA replication</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600058" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0666666">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A RNA  extraction is a nucleic acid extration where the desired output material is RNA</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">requested by Helen Parkinson for MO</OBI_0000275>
    <OBI_0000288 xml:lang="en">RNA extraction</OBI_0000288>
    <rdfs:label xml:lang="en">RNA extraction</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0666667" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000272">
    <OBI_0000291 xml:lang="en">Definition: Protocol is a plan outlining a set of instructions which can be realized as a protocol application. Example: The SOP describing the execution of a clinical trial. Affymetrix Mass 5 analysis. The dose and route of administration of myosin into a mouse.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">protocol</OBI_0000288>
    <rdfs:label xml:lang="en">protocol</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000344" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000115">
    <OBI_0000286 xml:lang="en">clinical study design</OBI_0000286>
    <OBI_0000291 xml:lang="en">an intervention design is a study design in which treatments (perturbations or intervention) defined as a combination of values taken by independant variable manipulated by the experimentalists are applied to the recruited subjects assigned (possibly by applying specific methods) to treatment groups. The specificity of intervention design is the fact that independent variables are being manipulated and a response of the biological system is evaluated via response variables as monitored by possibly a series of assays.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philppe Rocca-Serra</OBI_0000274>
    <OBI_0000288 xml:lang="en">intervention design</OBI_0000288>
    <rdfs:label xml:lang="en">intervention design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000297" />
        <owl:someValuesFrom>
          <owl:Restriction>
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000300" />
            <owl:someValuesFrom>
              <owl:Class>
                <owl:intersectionOf rdf:parseType="Collection">
                  <owl:Restriction>
                    <owl:onProperty rdf:resource="http://www.obofoundry.org/ro/ro.owl#has_part" />
                    <owl:someValuesFrom>
                      <owl:Restriction>
                        <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000293" />
                        <owl:someValuesFrom>
                          <owl:Restriction>
                            <owl:onProperty>
                              <owl:ObjectProperty rdf:about="http://purl.obofoundry.org/obo/OBI_0000316" />
                            </owl:onProperty>
                            <owl:someValuesFrom rdf:resource="http://purl.obofoundry.org/obo/OBI_0000090" />
                          </owl:Restriction>
                        </owl:someValuesFrom>
                      </owl:Restriction>
                    </owl:someValuesFrom>
                  </owl:Restriction>
                  <rdf:Description rdf:about="http://www.ifomis.org/bfo/1.1/span#Process" />
                </owl:intersectionOf>
              </owl:Class>
            </owl:someValuesFrom>
          </owl:Restriction>
        </owl:someValuesFrom>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600045">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">any protocol resulting in information on the 3-dimensional qualities of a biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of NMR Spectroscopy to determine the 3D-Structure of the binding of an epitope to an MHC molecule</OBI_0000287>
    <OBI_0000288 xml:lang="en">structure assay</OBI_0000288>
    <rdfs:label xml:lang="en">structure assay</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600014">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application in which one input material is separated (in space) into two or more output materials</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000287 xml:lang="en">Using a cell sorter to separate a mixture of T cells into two fractions; one with surface receptor CD8 and the other lacking the receptor</OBI_0000287>
    <OBI_0000288 xml:lang="en">material separation</OBI_0000288>
    <rdfs:label xml:lang="en">material separation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
    <rdfs:subClassOf>
      <owl:Class>
        <owl:intersectionOf rdf:parseType="Collection">
          <owl:Restriction>
            <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1</owl:cardinality>
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000293" />
          </owl:Restriction>
          <owl:Restriction>
            <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2</owl:minCardinality>
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000299" />
          </owl:Restriction>
        </owl:intersectionOf>
      </owl:Class>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000187">
    <OBI_0000291 xml:lang="en">A data format specification is a plan which organizes information. Example: The ISO document specifying what encompasses an XML document; The instructions in a XSD file</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">data format specification</OBI_0000288>
    <rdfs:label xml:lang="en">data format specification</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.geneontology.org/formats/oboInOwl#Class_1" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500016">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A fractional factorial design is_a study design in which only an adequately chosen fraction of the treatment combinations required for the complete factorial experiment is selected to be run</OBI_0000291>
    <OBI_0000279 xml:lang="en">http://www.itl.nist.gov/div898/handbook/pri/section3/pri334.htm From ASQC (1983) Glossary &amp; Tables for Statistical Quality Control</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">fractional factorial design</OBI_0000288>
    <rdfs:label xml:lang="en">fractional factorial design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600047">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of a chemical or biochemical means to infer the sequence of a biomaterial</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of the Sanger method of DNA sequencing to determine the order of the nucleotides in a DNA template</OBI_0000287>
    <OBI_0000288 xml:lang="en">sequencing</OBI_0000288>
    <rdfs:label xml:lang="en">sequencing</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500015">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">2x2 factorial design is factorial design which has 2 experimental factors (aka independent variables) and 2 factor levels per experimental factors</OBI_0000291>
    <OBI_0000279 xml:lang="en">PMID: 17561240</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17561240-The present experiment evaluates the effects of intermittent exposure to a social stimulus on ethanol and water drinking in rats. Four groups of rats were arranged in a 2x2 factorial design with 2 levels of Social procedure (Intermittent Social vs Continuous Social) and 2 levels of sipper Liquid (Ethanol vs Water). Intermittent Social groups received 35 trials per session. Each trial consisted of the insertion of the sipper tube for 10 s followed by lifting of the guillotine door for 15 s. The guillotine door separated the experimental rat from the conspecific rat in the wire mesh cage during the 60 s inter-trial interval. The Continuous Social groups received similar procedures except that the guillotine door was raised during the entire duration of the session. For the Ethanol groups, the concentrations of ethanol in the sipper [3, 4, 6, 8, 10, 12, 14, and 16% (vol/vol)] increased across sessions, while the Water groups received 0% ethanol (water) in the sipper throughout the experiment. Both Social procedures induced more intake of ethanol than water. The Intermittent Social procedure induced more ethanol intake at the two highest ethanol concentration blocks (10-12% and 14-16%) than the Continuous Social procedure, but this effect was not observed with water. Effects of social stimulation on ethanol drinking are discussed.</OBI_0000287>
    <OBI_0000288 xml:lang="en">2x2 factorial design</OBI_0000288>
    <rdfs:label xml:lang="en">2x2 factorial design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500014">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">factorial design is_a Study design which is used to evaluate two or more factors simultaneously. The treatments are combinations of levels of the factors. The advantages of factorial designs over one-factor-at-a-time experiments is that they are more efficient and they allow interactions to be detected. In statistics, a factorial design experiment is an experiment whose design consists of two or more factors, each with discrete possible values or levels, and whose experimental units take on all possible combinations of these levels across all such factors. Such an experiment allows studying the effect of each factor on the response variable, as well as the effects of interactions between factors on the response variable.</OBI_0000291>
    <OBI_0000279 xml:lang="en">http://www.stats.gla.ac.uk/steps/glossary/anova.html#facdes And from wikipedia (01/03/2007): http://en.wikipedia.org/wiki/Factorial_experiment)</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17582121-Our objective was to examine the effects of dietary cation-anion difference (DCAD) with different concentrations of dietary crude protein (CP) on performance and acid-base status in early lactation cows. Six lactating Holstein cows averaging 44 d in milk were used in a 6 x 6 Latin square design with a 2 x 3 factorial arrangement of treatments: DCAD of -3, 22, or 47 milliequivalents (Na + K - Cl - S)/100 g of dry matter (DM), and 16 or 19% CP on a DM basis. Linear increases with DCAD occurred in DM intake, milk fat percentage, 4% fat-corrected milk production, milk true protein, milk lactose, and milk solids-not-fat. Milk production itself was unaffected by DCAD. Jugular venous blood pH, base excess and HCO3(-) concentration, and urine pH increased, but jugular venous blood Cl- concentration, urine titratable acidity, and net acid excretion decreased linearly with increasing DCAD. An elevated ratio of coccygeal venous plasma essential AA to nonessential AA with increasing DCAD indicated that N metabolism in the rumen was affected, probably resulting in more microbial protein flowing to the small intestine. Cows fed 16% CP had lower urea N in milk than cows fed 19% CP; the same was true for urea N in coccygeal venous plasma and urine. Dry matter intake, milk production, milk composition, and acid-base status did not differ between the 16 and 19% CP treatments. It was concluded that DCAD affected DM intake and performance of dairy cows in early lactation. Feeding 16% dietary CP to cows in early lactation, compared with 19% CP, maintained lactation performance while reducing urea N excretion in milk and urine.</OBI_0000287>
    <OBI_0000288 xml:lang="en">factorial design</OBI_0000288>
    <rdfs:label xml:lang="en">factorial design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000115" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600020">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the visual examination of cells or tissue (or images of them) with an assessment regarding a quality of the cells or tissue. Parts are: staining, imaging, judgement</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Compiled by Helen Parkinson for Transcriptomics thanks to Adam Witney</OBI_0000274>
    <OBI_0000275 xml:lang="en">need to incorporate parts\n---\nThis is a very vague term, it should be in the same place as transcriptomics, proteomics metaboloimcs. It is the 'study' of tissues, not the process of studying tissues\n</OBI_0000275>
    <OBI_0000287 xml:lang="en">the counting of the number of cells with fluorescent label at their surface to determine the percentage of the population which was activated</OBI_0000287>
    <OBI_0000288 xml:lang="en">histology</OBI_0000288>
    <rdfs:label xml:lang="en">histology</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600039">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to add methyl groups to molecules</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000275 xml:lang="en">Long format, assuming GO will have the process methylation defined, methylation_induction is realization of a protocol to induce the natural process of methylation</OBI_0000275>
    <OBI_0000287 xml:lang="en">the use of enzymes to add methyl groups to DNA molecules</OBI_0000287>
    <OBI_0000288 xml:lang="en">methylation</OBI_0000288>
    <rdfs:label xml:lang="en">methylation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000126" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000085">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">BFO to do</OBI_0000291>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">concretized protocol</OBI_0000288>
    <rdfs:label xml:lang="en">concretized protocol</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000260" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000270">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000320"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">PRS will add</OBI_0000291>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">algorithm</OBI_0000288>
    <rdfs:label xml:lang="en">algorithm</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.geneontology.org/formats/oboInOwl#Class_1" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000105">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to replace an organ or tissue of an organism</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">transplantation</OBI_0000288>
    <rdfs:label xml:lang="en">transplantation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000117">
    <OBI_0000291 xml:lang="en">is an assay where the output data is a datum with one of two values denoted success and failure.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">Bernoulli trial</OBI_0000288>
    <rdfs:label xml:lang="en">Bernoulli trial</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600065" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500023">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a compliance rule is a rule which ensures a compliance process occurs</OBI_0000291>
    <OBI_0000279 xml:lang="en">PRS</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">compliance rule</OBI_0000288>
    <rdfs:label xml:lang="en">compliance rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500021" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600041">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to create an output material with an increased density of a material of interest that is part of the input material by separating other parts of the input material</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">Evaporation of the solution containing DNA to increase the concentration of the DNA molecules</OBI_0000287>
    <OBI_0000288 xml:lang="en">concentrate</OBI_0000288>
    <rdfs:label xml:lang="en">concentrate</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0666667">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a material separation to recover the nuceic acid fraction of an input material</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">requested by Helen Parkinson for MO. Could be defined class</OBI_0000275>
    <OBI_0000287 xml:lang="en">Phenol / chlorophorm extraction disolvation of protein content folllowed by ethanol precipitation of the nucleic acid fraction over night in the fridge followed by centrifugation to obtain a nucleic acid pellet.</OBI_0000287>
    <OBI_0000288 xml:lang="en">nucleic acid extraction</OBI_0000288>
    <rdfs:label xml:lang="en">nucleic acid extraction</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600004">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">enrollment of humans based on eligibility criteria for an investigation</OBI_0000291>
    <OBI_0000279 xml:lang="en">IEDB</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000275 xml:lang="en">criteria come from plan / clinical trial branch</OBI_0000275>
    <OBI_0000287 xml:lang="en">enlisting familiy members of HIV patients into a study</OBI_0000287>
    <OBI_0000288 xml:lang="en">human subject enrollment</OBI_0000288>
    <rdfs:label xml:lang="en">human subject enrollment</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000296" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500000">
    <OBI_0000286 xml:lang="en">experimental design</OBI_0000286>
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A formal description of the constraints on the possible configurations of an experiment which is subject to given conditions. A design is sometimes called an experimental design. source:http://mathworld.wolfram.com/Design.html\nEditor Note: Philippe Rocca-Serra added this; Description of how an experiment is performed. Experiments are designed by applying applications to biomaterials in an ordered fashion. Applications define protocols which are used to moving biomaterial through a series of manipulations to generate one or more desired products. methods describe the particulars of the manipulation, reagents and associated materials used in the manipulation of the biomaterial.</OBI_0000291>
    <OBI_0000279 xml:lang="en">KPC</OBI_0000279>
    <OBI_0000274 xml:lang="en">KPC</OBI_0000274>
    <OBI_0000275 xml:lang="en">From Kevin Clancy not yet discussed</OBI_0000275>
    <OBI_0000287 xml:lang="en">TODO:</OBI_0000287>
    <OBI_0000288 xml:lang="en">study design</OBI_0000288>
    <rdfs:label xml:lang="en">study design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000344" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600034">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to cause a material to precipitate (becoming a solid) out of solution. Input is a solution, ouput is a solution plus a solid component (the precipitate)</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The use of ethanol to precipitate DNA molecules from a solution containing DNA</OBI_0000287>
    <OBI_0000288 xml:lang="en">precipitation</OBI_0000288>
    <rdfs:label xml:lang="en">precipitation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600018">
    <OBI_0000286 xml:lang="en">aliquoting</OBI_0000286>
    <OBI_0000286 xml:lang="en">apportioning</OBI_0000286>
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A material separtion in  which the input substance is partitioned into a number of portions that are similar in composition.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Bjoern Peters</OBI_0000274>
    <OBI_0000287 xml:lang="en">pouring 50 mL aliquots of fetal calf serum into conical tubes from a 500 mL stock</OBI_0000287>
    <OBI_0000288 xml:lang="en">material portioning</OBI_0000288>
    <rdfs:label xml:lang="en">material portioning</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000355">
    <OBI_0000291 xml:lang="en">is an investigation with the goal to test one or more hypothesis</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">hypothesis driven investigation</OBI_0000288>
    <rdfs:label xml:lang="en">hypothesis driven investigation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000066" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000094">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A material transformation is a protocol_application carried out to geneerate output material from the input material</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000275 xml:lang="en">we may not need this one in the long term, and just keep the children? (TC 14 June)</OBI_0000275>
    <OBI_0000288 xml:lang="en">material transformation</OBI_0000288>
    <rdfs:label xml:lang="en">material transformation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000069" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500022">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a stopping rule (criterion) is_a *rule* which causes a *stopping process* to happen</OBI_0000291>
    <OBI_0000279 xml:lang="en">PRS</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17591081-BACKGROUND/AIMS: To investigate the viral kinetics of Chinese CHC patients received pegylated interferon plus ribavirin and examine the impact of HCV genotypes and severity of liver disease. METHODOLOGY: 65 treatment-naove CHC patients who finished a 24-week therapy with peginterferon (alpha-2b (1.5 mcg/kg/week) plus ribavirin (1000-1200 mg /day) and 24 weeks of follow-up were enrolled. Hepatic fibrosis was graded by the METAVIR scoring system. Serum quantitative HCV RNA was determined by Versant HCV RNA 3.0 assay (Bayer Inc.). RESULTS: Genotype non-1 patients responded quickly and a higher percentage of them achieved undetectable HCV RNA (&lt; 615 IU/mL) at week 4 compared with genotype 1 patients (93% vs. 69%, p = 0.018). Degree of hepatic fibrosis significantly affected end-of-treatment and sustained response (SVR). For patients who did not achieve early virological response (EVR), the negative predictive value for SVR was 100%. In genotype 1 patients, undetectable HCV RNA by week 4 was a good marker to predict treatment response, with a positive predictive value of 84% and a negative predictive value of 82%. CONCLUSIONS: EVR can be applied to Chinese patients as an early stopping rule. A 24-week duration of pegylated IFN/ribavirin might be adequate for genotype 1 patients who rapidly responded to therapy.</OBI_0000287>
    <OBI_0000288 xml:lang="en">stopping rule</OBI_0000288>
    <rdfs:label xml:lang="en">stopping rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500021" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_9999994">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">An assay in which radioactive chromium is absorbed by cells and released into supernatant when the cells die. The amount of radioactivity measured in the supernatant is a proxy for the number of cells that have died.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000287 xml:lang="en">from http://cvi.asm.org/cgi/content/full/11/2/255 (and slightly simplified)\nAutologous EBV-transformed B-LCL were used as target cells for the influenza virus-specific CTL assays. Equal volumes of target (5 x 10E4 cells/ml) and effector cells were added to triplicate wells of 96-well tissue culture plates, and 1:2 serial dilutions of effectors were made, producing effector-to-target (E:T) ratios of 100:1, 50:1, 25:1, and 12.5:1 (9). Spontaneous release of 51Cr was assessed by the incubation of target cells in medium alone, and maximum release of 51Cr was determined by the incubation of target cells in 0.1% Triton X-100 (Sigma-Aldrich).\nAfter a 4-h incubation of the effector cells with the target cells at 37Â°C in 6% CO2, supernatants were collected following brief centrifugation. The supernatant was collected into filters of supernatant collection system harvesting frames (Molecular Devices Skatron, Sunnyvale, Calif.) and transferred to polystyrene tubes to be counted with the LKB 1272 Clinigamma counter (Wallac).\nPercent specific was determined with the following equation: (experimental 51Cr release - spontaneous 51Cr release)/(maximum 51Cr release - spontaneous 51Cr release) x 100.</OBI_0000287>
    <OBI_0000288 xml:lang="en">chromium release assay</OBI_0000288>
    <rdfs:label xml:lang="en">chromium release assay</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600037">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">The act of taking part of a homogeneous cell culture and creating one or more additional separate cultures of similar qualities. input: cell_culture, output cell_culture min cardinality 2. part of cell culturing</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000287 xml:lang="en">The act of taking a cell culture of high density, counting the cells, removing part of the cells, and re-seeding a select number of the cells into new flasks with fresh tissue culture media.</OBI_0000287>
    <OBI_0000288 xml:lang="en">cell culture splitting</OBI_0000288>
    <rdfs:label xml:lang="en">cell culture splitting</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600014" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000201">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">An assay in which a material's radioactivity is measured.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000287 xml:lang="en">Measurment of the radioactivity of a supernatant, as in chromium_release_assay.</OBI_0000287>
    <OBI_0000288 xml:lang="en">radioactivity detection</OBI_0000288>
    <rdfs:label xml:lang="en">radioactivity detection</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
    <rdfs:subClassOf>
      <owl:Class>
        <owl:intersectionOf rdf:parseType="Collection">
          <owl:Restriction>
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000293" />
            <owl:someValuesFrom rdf:resource="http://www.ifomis.org/bfo/1.1/snap#Object" />
          </owl:Restriction>
          <owl:Restriction>
            <owl:onProperty rdf:resource="http://purl.obofoundry.org/obo/OBI_0000299" />
            <owl:someValuesFrom>
              <owl:Class>
                <owl:intersectionOf rdf:parseType="Collection">
                  <owl:Restriction>
                    <owl:onProperty>
                      <rdf:Description rdf:about="http://purl.obofoundry.org/obo/OBI_0000314">
                        <OBI_0000291 xml:lang="en">A relation between continuant instances c1 and c2 where within a protocol 
    application, measurement of c1 is related to a what would be the 
    measurement of c2.</OBI_0000291>
                      </rdf:Description>
                    </owl:onProperty>
                    <owl:someValuesFrom>
                      <rdf:Description rdf:about="http://purl.obofoundry.org/obo/OBI_0000019">
                        <rdfs:comment xml:lang="en">move to dependent.owl</rdfs:comment>
                      </rdf:Description>
                    </owl:someValuesFrom>
                  </owl:Restriction>
                  <rdf:Description rdf:about="http://purl.obofoundry.org/obo/OBI_0000305" />
                </owl:intersectionOf>
              </owl:Class>
            </owl:someValuesFrom>
          </owl:Restriction>
        </owl:intersectionOf>
      </owl:Class>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600043">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the introduction and integration of genetic material into a cell or organism in order to alter its genetic make-up</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The transduction of E. coli through the introduction of a plasmid encoding for M. avium p35</OBI_0000287>
    <OBI_0000288 xml:lang="en">genetic transformation</OBI_0000288>
    <rdfs:label xml:lang="en">genetic transformation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000335">
    <OBI_0000291 xml:lang="en">Investigation_design is a plan for an investigation. definition_source: OBI.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">investigation design</OBI_0000288>
    <rdfs:label xml:lang="en">investigation design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000344" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000066">
    <OBI_0000291 xml:lang="en">Investigation is a process in which data are gathered from one or more protocol applicationswith the goal of reaching conclusions . It is guided by the realization of a investigation_design</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">Altdef: A set of studies that are designed to address a related question.  It may include individual studies that are domain specific(?) , microarray, proteomics.</OBI_0000275>
    <OBI_0000275 xml:lang="en">It s up for discussion if a single protocol can be an investigation</OBI_0000275>
    <OBI_0000288 xml:lang="en">investigation</OBI_0000288>
    <rdfs:label xml:lang="en">investigation</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600062" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000349">
    <OBI_0000291 xml:lang="en">is a plan to carry out a process or an event if the trigger condition is fulfilled</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">instruction trigger</OBI_0000288>
    <rdfs:label xml:lang="en">instruction trigger</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.geneontology.org/formats/oboInOwl#Class_1" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500006">
    <OBI_0000286 xml:lang="en">independent measure design</OBI_0000286>
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment</OBI_0000291>
    <OBI_0000279 xml:lang="en">http://www.holah.karoo.net/experimentaldesigns.htm</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">PMID: 17408389-Purpose: Proliferative vitreoretinopathy (PVR) is the most important reason for blindness following retinal detachment. Presently, vitreous tamponades such as gas or silicone oil cannot contact the lower part of the retina. A heavier-than-water tamponade displaces the inflammatory and PVR-stimulating environment from the inferior area of the retina. The Heavy Silicone Oil versus Standard Silicone Oil Study (HSO Study) is designed to answer the question of whether a heavier-than-water tamponade improves the prognosis of eyes with PVR of the lower retina. Methods: The HSO Study is a multicentre, randomized, prospective controlled clinical trial comparing two endotamponades within a two-arm parallel group design. Patients with inferiorly and posteriorly located PVR are randomized to either heavy silicone oil or standard silicone oil as a tamponading agent. Three hundred and fifty consecutive patients are recruited per group. After intraoperative re-attachment, patients are randomized to either standard silicone oil (1000 cSt or 5000 cSt) or Densiron((R)) as a tamponading agent. The main endpoint criteria are complete retinal attachment at 12 months and change of visual acuity (VA) 12 months postoperatively compared with the preoperative VA. Secondary endpoints include complete retinal attachment before endotamponade removal, quality of life analysis and the number of retina affecting re-operation within 1 year of follow-up. Results: The design and early recruitment phase of the study are described. Conclusions: The results of this study will uncover whether or not heavy silicone oil improves the prognosis of eyes with PVR.</OBI_0000287>
    <OBI_0000288 xml:lang="en">parallel group design</OBI_0000288>
    <rdfs:label xml:lang="en">parallel group design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000115" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600013">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">is an aquisition of information from an organization that provides information.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">Bjoern Peters</OBI_0000274>
    <OBI_0000287 xml:lang="en">Gathering all influenza HA sequences from GenBank, Retrieveing HLA allele frequencies in the North American populations from dbMHC</OBI_0000287>
    <OBI_0000288 xml:lang="en">data collection</OBI_0000288>
    <rdfs:label xml:lang="en">data collection</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600008" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600054">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of environmental conditions to select for the organism or cells that have a certain trait</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PERSON:Kevin Clancy</OBI_0000274>
    <OBI_0000287 xml:lang="en">The insertion of a gene for antibiotic resistance into a cell population and subsequent growth in the presence of the antibiotic to select for those cells which were successfully transfected</OBI_0000287>
    <OBI_0000288 xml:lang="en">selection by survival</OBI_0000288>
    <rdfs:label xml:lang="en">selection by survival</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600056">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">the use of enzymes to cut proteins</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">\n---\nenzymatic digestion\n</OBI_0000275>
    <OBI_0000287 xml:lang="en">the use of trypsin to cleave pepsin into peptide fragments</OBI_0000287>
    <OBI_0000288 xml:lang="en">protease cleavage</OBI_0000288>
    <rdfs:label xml:lang="en">protease cleavage</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000231" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600044">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application to separate cells and/or cellular secretions from an anatomical space by the introduction and removal of fluid</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">This is not washing, in which case the material of interest is not the resulting fluid</OBI_0000275>
    <OBI_0000287 xml:lang="en">the collection of bronchoalveolar lavage fluid (BAL) from the lungs of mice in order to study the cytokines present</OBI_0000287>
    <OBI_0000288 xml:lang="en">lavage</OBI_0000288>
    <rdfs:label xml:lang="en">lavage</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600005" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500002">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A repeated measure design is a study design which use the same individuals and exposure them to a set of conditions. The effect of order and practice can be confounding factor in such designs</OBI_0000291>
    <OBI_0000279 xml:lang="en">http://www.holah.karoo.net/experimentaldesigns.htm</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">repeated measure design</OBI_0000288>
    <rdfs:label xml:lang="en">repeated measure design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000115" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500018">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A replicate experimental design type is where a series of replicates are performed to evaluate reproducibility or as a pilot study to determine the appropriate number of replicates for a subsequent experiments.</OBI_0000291>
    <OBI_0000279 xml:lang="en">MO_885</OBI_0000279>
    <OBI_0000274 xml:lang="en">Philippe Rocca-Serra on behalf of MO</OBI_0000274>
    <OBI_0000275 xml:lang="en">MO</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">replicate design</OBI_0000288>
    <rdfs:label xml:lang="en">replicate design</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500000" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000310">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000328"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">revisit?</OBI_0000291>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">adverse event trigger</OBI_0000288>
    <rdfs:label xml:lang="en">adverse event trigger</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000349" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000260">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">BFO to do</OBI_0000291>
    <OBI_0000288 xml:lang="en">concretized information entity</OBI_0000288>
    <rdfs:label xml:lang="en">concretized information entity</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://www.ifomis.org/bfo/1.1/snap#RealizableEntity" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0600003">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a protocol application during which a series of tests are made of a patient  leading to determination of disease state, or condition.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">(maybe CIO)</OBI_0000275>
    <OBI_0000288 xml:lang="en">clinical diagnosis</OBI_0000288>
    <rdfs:label xml:lang="en">clinical diagnosis</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0500024">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">a  standard compliance rule is a compliance rule which defines conformity to a representation standard</OBI_0000291>
    <OBI_0000279 xml:lang="en">PRS</OBI_0000279>
    <OBI_0000274 xml:lang="en">PRS</OBI_0000274>
    <OBI_0000275 xml:lang="en">MSI</OBI_0000275>
    <OBI_0000287 xml:lang="en">example to be added</OBI_0000287>
    <OBI_0000288 xml:lang="en">standard compliance rule</OBI_0000288>
    <rdfs:label xml:lang="en">standard compliance rule</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0500023" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000183">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A mass spectrometry assay is an assay to measure and analyze the molecules of a sample based on it's mass and charge. definition_source: OBI.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000288 xml:lang="en">mass spectrometry assay</OBI_0000288>
    <rdfs:label xml:lang="en">mass spectrometry assay</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000070" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000035">
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">Place holder class, see editor note</OBI_0000291>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">Placeholder class. The terms beneath this need to play nice with each other. Needs to be done by someone with cloning experience</OBI_0000275>
    <OBI_0000288 xml:lang="en">_cloning placeholder</OBI_0000288>
    <rdfs:label xml:lang="en">_cloning placeholder</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0000094" />
  </owl:Class>
  <owl:Class rdf:about="http://purl.obofoundry.org/obo/OBI_0000073">
    <OBI_0000286 xml:lang="en">study</OBI_0000286>
    <OBI_0000285 xml:lang="en">Nutrigenomics</OBI_0000285>
    <OBI_0000281><OBI_0000266 rdf:about="http://purl.obofoundry.org/obo/OBI_0000323"/></OBI_0000281>
    <OBI_0000291 xml:lang="en">A sample_preparation_for_assay is a protocol_application including material_enrollments and biomaterial_transformations. definition_source: OBI.</OBI_0000291>
    <OBI_0000279 xml:lang="en">OBI branch derived</OBI_0000279>
    <OBI_0000274 xml:lang="en">PlanAndPlannedProcess Branch</OBI_0000274>
    <OBI_0000275 xml:lang="en">rem1: the 'relates to a set of biological materials' covers environmental samples and data</OBI_0000275>
    <OBI_0000275 xml:lang="en">move to defined class</OBI_0000275>
    <OBI_0000288 xml:lang="en">sample preparation for assay</OBI_0000288>
    <rdfs:label xml:lang="en">sample preparation for assay</rdfs:label>
    <rdfs:subClassOf rdf:resource="http://purl.obofoundry.org/obo/OBI_0600065" />
  </owl:Class>
  <owl:Ontology rdf:about="">
    <owl:versionInfo xml:lang="en">$Revision$</owl:versionInfo>
  </owl:Ontology>
  <rdf:Description rdf:about="http://obi.sourceforge.net/ontology/OBI.owl#OBI_95">
    <OBI_0000277 xml:lang="en">protocol_application</OBI_0000277>
  </rdf:Description>
  <rdf:Description rdf:about="http://obi.sourceforge.net/ontology/OBI.owl#OBI_260">
    <OBI_0000277 xml:lang="en">protocol_application</OBI_0000277>
  </rdf:Description>
</rdf:RDF>
